Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
1 to 16 of 16  Show
  1. 1
    "Complete sequencing and characterization of 21,243 full-length human cDNAs."
    Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.
    , Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.
    Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 12930 other entries.

  2. 2
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 2470 other entries.

  3. 3
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  4. 4
    "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
    The MGC Project Team
    Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
    Category: Sequences.
    Tissue: Testis.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 50481 other entries.

  5. 5
    Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 18092 other entries.

  6. 6
    "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome."
    Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L., Ye M., Zou H.
    J. Proteomics 96:253-262(2014) [PubMed] [Europe PMC] [Abstract]
    Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Category: Sequences.
    Tissue: Liver.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 11535 other entries.

  7. 7
    Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 6356 other entries.

  8. 8
    "Evaluation of the novel gene Rabl3 in the regulation of proliferation and motility in human cancer cells."
    Li Q., Wang L., Zeng L., Zhang Y., Li K., Jin P., Su B., Wang L.
    Oncol. Rep. 24:433-440(2010) [PubMed] [Europe PMC] [Abstract]
    Annotation: Rabl3 can be considered as a novel candidate in the control of tumorigenesis and as a new target for anticancer treatment.Imported.
    Source: GeneRIF:285282.

    This publication is mapped to 1 other entry.

  9. 9
    "The human-bacterial pathogen protein interaction networks of Bacillus anthracis, Francisella tularensis, and Yersinia pestis."
    Dyer M.D., Neff C., Dufford M., Rivera C.G., Shattuck D., Bassaganya-Riera J., Murali T.M., Sobral B.W.
    PLoS ONE 5:e12089-e12089(2010) [PubMed] [Europe PMC] [Abstract]
    Category: Interaction.
    Source: IntAct:Q5HYI8.

    This publication is mapped to 5905 other entries.

  10. 10
    "The PI(3)P interactome from a colon cancer cell."
    Catimel B., Kapp E., Yin M.X., Gregory M., Wong L.S., Condron M., Church N., Kershaw N., Holmes A.B., Burgess A.W.
    J Proteomics 82:35-51(2013) [PubMed] [Europe PMC] [Abstract]
    Category: Interaction.
    Source: IntAct:Q5HYI8.

    This publication is mapped to 650 other entries.

  11. 11
    Category: Interaction.
    Source: IntAct:Q5HYI8.

    This publication is cited by 10 and mapped to 71 other entries.

  12. 12
    "A human interactome in three quantitative dimensions organized by stoichiometries and abundances."
    Hein M.Y., Hubner N.C., Poser I., Cox J., Nagaraj N., Toyoda Y., Gak I.A., Weisswange I., Mansfeld J., Buchholz F., Hyman A.A., Mann M.
    Cell 163:712-723(2015) [PubMed] [Europe PMC] [Abstract]
    Category: Interaction.
    Source: IntAct:Q5HYI8.

    This publication is mapped to 5387 other entries.

  13. 13
    Category: Interaction.
    Source: IntAct:Q5HYI8.

    This publication is mapped to 1812 other entries.

  14. 14
    "High Expression of Rab-like 3 (Rabl3) is Associated with Poor Survival of Patients with Non-Small Cell Lung Cancer via Repression of MAPK8/9/10-Mediated Autophagy."
    Zhang W., Sun J., Luo J.
    Med. Sci. Monit. 22:1582-1588(2016) [PubMed] [Europe PMC] [Abstract]
    Annotation: We examine the correlation between the expression level of Rabl3 and survival of non-small cell lung cancer (NSCLC) patients in three independent cohorts containing 484 patients. We found high expression of Rabl3 might inhibit cell death in non-small cell lung cancer via repression of MAPK8/9/10-mediated autophagyImported.
    Source: GeneRIF:285282.

    This publication is mapped to 1 other entry.

  15. 15
    "The overexpression of Rabl3 is associated with pathogenesis and clinicopathologic variables in hepatocellular carcinoma."
    Pan Y., Liu Z., Feng Z., Hui D., Huang X., Tong D., Jin Y.
    Tumour Biol. 39:1010428317696230-1010428317696230(2017) [PubMed] [Europe PMC] [Abstract]
    Annotation: Our studies suggest that the Rabl3 is a valuable marker of hepatocellular carcinoma progression and that the overexpression of Rabl3 plays an important role in the development and pathogenesis of hepatocellular carcinoma.Imported.
    Source: GeneRIF:285282.

    This publication is mapped to 1 other entry.

  16. 16
    "Overexpression of Rabl3 and Cullin7 is associated with pathogenesis and poor prognosis in hepatocellular carcinoma."
    An J., Liu Z., Liang Q., Pan Y., Li H., Wang R., Jin Y.
    Hum. Pathol. 67:146-151(2017) [PubMed] [Europe PMC] [Abstract]
    Annotation: Hepatocellular carcinoma patients with positive expression for both Rabl3 and Cullin7 had a remarkably shorter survival time compared with patients with negative expression for both proteins.Imported.
    Source: GeneRIF:285282.

    This publication is mapped to 4 other entries.

1 to 16 of 16  Show

We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.

Do not show this banner again
UniProt is an ELIXIR core data resource
Main funding by: National Institutes of Health